[Blood transfusions in maxillofacial surgery] NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Blood transfusions in maxillofacial surgery]

G Stomatol Ortognatodonzia. 1989 Jul-Dec;8(4):29-30. Unique Identifier : AIDSLINE MED/91034483
Deangeli R; De Angelis V

Abstract: In the last few years a codification of maxillo-facial surgical techniques has been reached. This has been possible because of a close interaction among different specialists. The use of blood transfusion must be carefully evaluated because of the different risks involved. The transmission of infectious agents like HIV and HCV viruses is still a matter of major concern. Furthermore, Gant in a '81 issue of Lancet suggested that blood transfusion in oncological patients may lead to neoplastic relapse by depressing the immune system. Other studies seem to confirm these data, although statistical evaluation of the results was not free of oriticism. Nevertheless, it appears that there is a correlation between the amount of transfused blood and the worsening of the prognosis. We take into consideration the risk of depressing the immune system by transfusing homologous blood. We then define the forensic medical problems related to blood transfusion also in view of recent sentences of the Court on the subject.
Keywords: *Blood Transfusion/ADVERSE EFFECTS Dental Care for Disabled English Abstract Hepatitis C/TRANSMISSION Human HIV Infections/TRANSMISSION Immunosuppression/*ADVERSE EFFECTS Neoplasm Recurrence, Local/ETIOLOGY Surgery, Oral/*METHODS JOURNAL ARTICLEKWDbloodtransfusion/adverseeffectsdentalcarefordisabledenglishabstracthepatitisc/transmissionhumanhivinfections/transmissionimmunosuppression/KWDadverseeffectsneoplasmrecurrence,local/etiologysurgery,oral/KWDmethodsjournalarticle
910228
M9120698

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .